Skip to main content
Premium Trial:

Request an Annual Quote

Roche Cobas TV/MG Test Gets CE-IVD Mark

NEW YORK (GenomeWeb) – Roche today announced it received the CE-IVD mark for the Cobas TV/MG test for use on the Cobas 6800/8800 systems.

The test allows for the direct detection of Trichomonas vaginalis and/or Mycoplasma genitalium DNA in symptomatic as well as asymptomatic patients. Roche launched the test today.

Cobas TV/MG has been validated for use with the same full set of female urogenital specimens that is used with Cobas NT/NG for Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae testing. It also has been validated for use with male urine, and, according to Roche, is the first CE-IVD molecular test to receive a claim for combo TV/MG testing using a meatal swab specimen.

"By coupling Cobas TV/MG with recently launched Cobas CT/NG … laboratories can now have the most flexible, high-throughput testing solution on the market today," Uwe Oberlaender, head of Roche Molecular Diagnostics, said in a statement. "Labs can now simultaneously process, from a single patient sample, any combination of CT, NG, TV, and MG, which provides clinicians the valuable information they need to properly [diagnose] STIs and improve patient care."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.